Skip to main content
. Author manuscript; available in PMC: 2013 Oct 6.
Published in final edited form as: Neuroscience. 2012 Mar 2;210:243–248. doi: 10.1016/j.neuroscience.2012.02.036

Figure 1.

Figure 1

Intra-paraventricular thalamic (PVT) orexin-A differentially increases dopamine levels in limbic regions. (A) Illustrates dopamine content in the medial Prefrontal Cortex (mPFC) following 1 or 5 nmole orexin-A administered directly into the paraventricular thalamus (PVT). (B) Depicts significantly elevated dopamine content in the nucleus accumbens (NAcc) following 1 or 5 nmole orexin-A administered directly into the PVT. (* p<0.05).